These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38793589)

  • 61. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Takazawa S; Kotaki T; Nakamura S; Utsubo C; Kameoka M
    Virus Res; 2023 Sep; 334():199176. PubMed ID: 37473963
    [TBL] [Abstract][Full Text] [Related]  

  • 64. SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    Pohl MO; Busnadiego I; Kufner V; Glas I; Karakus U; Schmutz S; Zaheri M; Abela I; Trkola A; Huber M; Stertz S; Hale BG
    PLoS Biol; 2021 Mar; 19(3):e3001006. PubMed ID: 33760807
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
    Wang X; Zhao Y; Yan F; Wang T; Sun W; Feng N; Wang W; Wang H; He H; Yang S; Xia X; Gao Y
    J Virol; 2021 Aug; 95(18):e0060021. PubMed ID: 34106002
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.
    Gori Savellini G; Anichini G; Manetti F; Trivisani CI; Cusi MG
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793572
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The m
    Liu J; Xu YP; Li K; Ye Q; Zhou HY; Sun H; Li X; Yu L; Deng YQ; Li RT; Cheng ML; He B; Zhou J; Li XF; Wu A; Yi C; Qin CF
    Cell Res; 2021 Apr; 31(4):404-414. PubMed ID: 33510385
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
    Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
    J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation.
    Lee SY; Kim DW; Jung YT
    Virus Genes; 2022 Jun; 58(3):172-179. PubMed ID: 35322356
    [TBL] [Abstract][Full Text] [Related]  

  • 70. JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis.
    Son J; Huang S; Zeng Q; Bricker TL; Case JB; Zhou J; Zang R; Liu Z; Chang X; Darling TL; Xu J; Harastani HH; Chen L; Gomez Castro MF; Zhao Y; Kohio HP; Hou G; Fan B; Niu B; Guo R; Rothlauf PW; Bailey AL; Wang X; Shi PY; Martinez ED; Brody SL; Whelan SPJ; Diamond MS; Boon ACM; Li B; Ding S
    mBio; 2022 Feb; 13(1):e0337721. PubMed ID: 35038906
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
    Despres HW; Mills MG; Shirley DJ; Schmidt MM; Huang ML; Roychoudhury P; Jerome KR; Greninger AL; Bruce EA
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35058348
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.
    Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ
    Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH.
    Rensen E; Pietropaoli S; Mueller F; Weber C; Souquere S; Sommer S; Isnard P; Rabant M; Gibier JB; Terzi F; Simon-Loriere E; Rameix-Welti MA; Pierron G; Barba-Spaeth G; Zimmer C
    Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 34996842
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction.
    Kim DH; Ahn HS; Go HJ; Kim DY; Kim JH; Lee JB; Park SY; Song CS; Lee SW; Ha SD; Choi C; Choi IS
    Sci Rep; 2021 Nov; 11(1):21462. PubMed ID: 34728736
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.
    Mei M; Cupic A; Miorin L; Ye C; Cagatay T; Zhang K; Patel K; Wilson N; McDonald WH; Crossland NA; Lo M; Rutkowska M; Aslam S; Mena I; Martinez-Sobrido L; Ren Y; García-Sastre A; Fontoura BMA
    Proc Natl Acad Sci U S A; 2024 May; 121(22):e2314166121. PubMed ID: 38768348
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
    Shema Mugisha C; Vuong HR; Puray-Chavez M; Bailey AL; Fox JM; Chen RE; Wessel AW; Scott JM; Harastani HH; Boon ACM; Shin H; Kutluay SB
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
    Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
    Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.
    Chang JJ; Rawlinson D; Pitt ME; Taiaroa G; Gleeson J; Zhou C; Mordant FL; De Paoli-Iseppi R; Caly L; Purcell DFJ; Stinear TP; Londrigan SL; Clark MB; Williamson DA; Subbarao K; Coin LJM
    Cell Rep; 2021 May; 35(6):109108. PubMed ID: 33961822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.